The Next Step in Moderate Asthma
Posted on August 11, 2008 - Filed Under Health | Leave a Comment
Patients in the moderate group who are still symptomatic with reduced activity and flow rates despite the combination of a long-acting B2-adrenergic agonist and medium doses of an inhaled corticosteroid will require additional second-line therapy. For bronchodilatation, adding an oral preparation of the B-agonist, theophylline, and/or ipratropium bromide may be helpful.
Those with nocturnal symptoms may respond to evening administration of a long-acting B-agonist or theophylline. If attacks continue to be frequent a trial of an additional anti-inflammatory agent is the next step. An anti-leukotriene or cromolyn or nedocromil may be added. It should be emphasized again that the decision to start or stop medications should be based on objective findings (spirometry or peak flow readings) in addition to the patient’s symptoms and frequency of attacks.
Read More..>>The Next Step in Moderate Asthma
Posted on August 10, 2008 - Filed Under Health | Leave a Comment
Patients in the moderate group who are still symptomatic with reduced activity and flow rates despite the combination of a long-acting B2-adrenergic agonist and medium doses of an inhaled corticosteroid will require additional second-line therapy. For bronchodilatation, adding an oral preparation of the B-agonist, theophylline, and/or ipratropium bromide may be helpful.
Those with nocturnal symptoms may respond to evening administration of a long-acting B-agonist or theophylline. If attacks continue to be frequent a trial of an additional anti-inflammatory agent is the next step. An anti-leukotriene or cromolyn or nedocromil may be added. It should be emphasized again that the decision to start or stop medications should be based on objective findings (spirometry or peak flow readings) in addition to the patient’s symptoms and frequency of attacks.
Read More..>>
